Our 2024 Partners

Lead Partner

2024 Partner - Biose

Biose Industrie

Biose Industrie is a Contract Development and Manufacturing Organization (CDMO), specialised in Live Biotherapeutic Products. Founded in 1951 by pharmacists and microbiologists, Biose Industrie has been manufacturing drug substance and drug products based on microorganisms for 60 years. Company, with 10 000m² of GMP facilty, offers product development at laboratory and pilot scale specialised in microbiology for aerobie and anaerobie strains and is Drug GMP certified for the manufacturing of API, clinical batches and commercial products.

www.biose.com/en/cdmo

Expertise Partner

CMC

Clinical Microbiomics | MS-Omics | Cosmos ID  

We offer end-to-end microbiome science solutions from discovery through clinical validation: short- and long-read DNA sequencing, metabolomics, RNA sequencing, multi-omics analysis and systems biology expertise. Pipelines are supported by CLIA-certified & ICH-GCP compliant NGS, metabolomic, and bioinformatics solutions. Access results via the CosmosID-HUB – a user-friendly cloud software for metagenomic and comparative analysis – or through customized reports. Bioinformatic pipelines enable clonal-level resolution, engraftment analysis correlated to phenotypes, and in-silico strain screens that de-risk selection and reduce development time.

www.cosmosid.com

BA_Final Logo 2024 (3) (1)

BA Sciences

BA Sciences is a cGMP compliant, FDA/DEA registered, ISO/IEC-17025:2017 certified analytical laboratory headquartered in Salem, NH. BA provides testing services to Pharmaceutical, Biopharmaceutical and Medical Device companies worldwide including: Analytical Testing and Method Development, Microbiological Testing and Environmental Monitoring Services, Biologics, Stability Testing & ICH-compliant Storage, Impurities Testing, Advanced Therapeutics and Extractables & Leachables Studies.

www.basciences.com

Program Partner

2024 Partner - List Labs

List Biological Laboratories, Inc.

List Labs is an experienced contract development and manufacturing organization (CDMO) harnessing bacteria’s potential for a healthier world. We offer a refreshingly flexible approach to clients seeking a CDMO for Live Biotherapeutic Products (LBP) derived from beneficial bacteria. Partner with List Labs as your CDMO and experience our uniquely collaborative and transparent culture.  With over 40 years of experience, our expertise encompasses aerobes, anaerobes, and spore formers, process development and scale up, analytical development and QC testing, aseptic filling, purification, lyophilization, and cGMP manufacturing for clinical trials and future commercial launch. List Labs produced the first LBP for clinical trial, before LBP was even an acronym, followed by dozens of products that led to successful clinical LBP programs. List Labs provides a solid foundation in science, purpose-built state of the art facilities, and a passionate team to ensure the success of your LBP project.

www.listlabs.com/services

2024 Partner - One Codex

One Codex

Accelerate your microbiome research with One Codex. Leading institutions trust One Codex for everything from microbiome sequencing to data analysis to reporting. Our advanced algorithms and curated database provide the most accurate picture of complex metagenomic samples. Meanwhile, an intuitive web-based interface makes data accessible to both bench scientists and computational biologists. We make it easier to solve problems in biology through genomics. Go from stool sample to results quickly and easily - One Codex gives structure to complex datasets, answering questions like: “What microbes are present?” and “What are they doing?”. An easy-to-use web platform, simple APIs for accessing data programmatically, and integrations with Illumina BaseSpace and other tools allow you and your collaborators to analyze hundreds or thousands of samples.

www.onecodex.com

Sacco System

Sacco System is the international biotech hub for food, nutraceutical, and pharmaceutical innovation. Cultures, probiotics, rennet, and many other ingredients to promote the culture of food and life. Innovative and customized solutions capable of responding to modern challenges of the Food & Health sector worldwide. After more than 70 years, CSL continue to focus on probiotic manufacturing, research and development for nutraceutical and pharmaceutical fields. Our know-how is not limited to LAB, but with our two facilities drug- GMP certified we can support companies in the development, process validation, and commercial production of probiotics, postbiotics, Next-Generation bacteria (obbligate aerobes and anaerobes strains) and biotherapeutics (BPs).

www.saccosystem.com

2024 Partner - Wacker

Wacker Chemie AG

Wacker Biotech is “THE MICROBIAL CDMO” – your partner of choice for process development and contract manufacturing of biopharmaceuticals (live microbial products, proteins, vaccines, plasmid DNA and mRNA). With its LIBATEC® platform, WACKER BIOTECH offers its clients vast experience in process development, optimization and manufacturing of Live Microbial Products (LMPs). LIBATEC® is suitable for a wide range of LMPs and fermentation regimes, allowing aerobic as well as specific anaerobic bacteria to be used. WACKER BIOTECH can perform such processes in a monoseptic manner, ensuring maximum culture purity and allowing use for specific routes of administration.

www.wacker.com/biologics

Exhibition Partners

2024 Partner - Anaerobe Systems

Anaerobe Systems

Anaerobe Systems produces the world’s only true pre-reduced anaerobically sterilized (PRAS) culture media: poured and packaged under anaerobic conditions. Founded over 40 years ago, for scientists by scientists, Anaerobe Systems has discovered practical and efficient ways to maximize anaerobic culture techniques.

www.anaerobesystems.com

2024 Partner - Bacthera

Bacthera

Bacthera, a CDMO located in Switzerland and Denmark, was founded to enable the Live Biotherapeutic Industry realize the therapeutic value of LBP's. We do so by supporting our customers with microbiology know-how, process expertise and industry changing innovation from pre-clinical to commercialization, from start-up to multinational pharma company, with best-in-class process technologies, strictly anaerobic strain handling and experienced staff. In sum, Bacthera actively work to de-risk the growing LBP industry with frictionless CMC development services and manufacturing solutions.

www.bacthera.com

2024-Partner-Biomodels

Biomodels

Biomodels LLC, a preclinical CRO, conducts predictive and translational studies for biotechnology and pharmaceutical companies in the areas of cancer/cancer supportive care, inflammatory & autoimmune diseases, and fibrosis, in addition to several other clinical indications. Biomodels specializes in (non-GLP) efficacy studies that optimize dose, schedule, and define mechanism of action. Additionally, Biomodels' state of the art Germ-Free and Gnotobiotic animal facility allows for the analysis of the role of the microbiota both in disease pathogenesis and in therapeutic efficacy.

www.biomodels.com

2024 Partner - EzBiome

EzBiome

EzBiome is a microbiome company specialized in precision taxonomy, curated databases, and cutting-edge genomic intelligence. Our mission is to accelerate the discovery and development of novel transformative therapeutics and companion diagnostics for microbiome-related diseases.

Our vision is to become world’s most customer centric microbiome company serving the global community with revolutionary platform and solutions to educate, inspire and harness microbiome treasure for the benefit of mankind.

ezbiome.com

sgs-qp-logo

SGS Quay Pharma

Quay Pharmaceuticals is a privately owned  CDMO working from FDA and MHRA inspected facilities. We are licenced to formulate and manufacture finished dosage forms for live biotherapeutics as well as small large molecules. In the live biotherapeutic space we work with consortia and single strain for drug delivery in oral, pessary and topical formats. Working as part of your team we rapidly and effectively bring products through development to First in Human studies to deliver success. We have worked on more than 50 plus strains from Phase I to Phase III projects and we are currently preparing for Commercial project.

www.quaypharma.com